Constantine Ward

Constantine Ward has held various roles in the clinical trial supply industry since 2012. Constantine began their career at PAREXEL as an Associate Clinical Logistics Leader / Senior Clinical Supply Coordinator, then moved to CSL Behring as a Clinical Trial Supply Consultant, Global Logistics. In 2013, they became the Owner & Clinical Trial Supply Optimization Consultant at Optimal. In 2016, they joined Catalent Pharma Solutions as a Senior Strategist, Clinical Supply & Project Delivery. In 2020, they were a Clinical Trial Supply Consultant at Origin Biosciences, QED Therapeutics, and Eidos Therapeutics. Constantine is currently a Senior Consultant to Regulatory & Technical Operations (CMC) at Secura Bio, Inc. and a Microsoft Consultant at the Atlantic Council.

Constantine Ward attended Technological University Dublin from 2000 to 2004, where they earned a Diploma in Applied Chemistry with Merit. Constantine then continued their studies at the same university from 2005 to 2007, graduating with a BSc in Pharmaceutial Technology with Distinction.